News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Andrea Necchi: Results from the ECHO-307/KEYNOTE-672 study
Andrea Necchi/youtube.com
Jul 26, 2024, 19:39

Andrea Necchi: Results from the ECHO-307/KEYNOTE-672 study

Andrea Necchi, Associate Professor at Vita-Salute San Raffaele University, shared on X:

“IDO1 inhibition was ineffective in urothelial carcinoma.

Pembrolizumab and epacadostat/placebo for cis-ineligible urothelial carcinoma:

ECHO-307/KEYNOTE-672 study, BMC Cancer, also negatively tested in neoadjuvant setting.”

Source: Andrea Necchi/X

Pembrolizumab plus either epacadostat or placebo for cisplatin-ineligible urothelial carcinoma: results from the ECHO-307/KEYNOTE-672 study.

Authors: Andrea Necchi, Michiel S. Van der Heijden, Dmytro Trukhin, Avivit Peer, Howard Gurney, Boris Y. Alekseev, Francis X. Parnis, Raya Leibowitz, Maria De Santis, Petros Grivas, Jason Clark, Mihaela Munteanu, Ritesh Kataria, Calvin Jia, Arjun V. Balar and Ronald de Wit.

Andrea Necchi

Andrea Necchi Arjun V. Balar Avivit Peer BMC Cancer Boris Y. Alekseev Calvin Jia cancer Dmytro Trukhin ECHO-307/KEYNOTE-672 study epacadostat Francis X. Parnis Howard Gurney Jason Clark Maria De Santis Michiel S. Van der Heijden Mihaela Munteanu OncoDaily Oncology pembrolizumab Petros Grivas Raya Leibowitz Ritesh Kataria Ronald de Wit urothelial carcinoma Vita-Salute San Raffaele University
Special Coverage
Blog
Apr 1, 2025, 19:09
Sally Susman: Thank you for joining me for Memoir March
Blog
Apr 1, 2025, 19:03
Megan-Claire J. Chase: Amazing team from Pink Warrior Angels at the exhibitor table right next to mine
Blog
Apr 1, 2025, 19:03
AIQ Solutions Tackles the Complex Reality of Unequal Metastatic Cancer Treatment Responses - CancerX
Blog
Apr 1, 2025, 18:58
Kevin Jackson Announces New Role as Lead Events Manager at UF Health Cancer Center
Blog
Apr 1, 2025, 18:48
Understanding Abnormal Coagulation at EPHOC 2025 - MENA Conference
Blog
Apr 1, 2025, 18:43
Debra Montague Joins Medscape Faculty Steering Committee as Patient Representative
Blog
Apr 1, 2025, 18:37
Binay Shah: Three Timely Levers to help bridge growing gap in Cancer Care
Insight
Apr 1, 2025, 18:33
Fumiko Ladd Chino: Over 1,200 scientists may leave the US due to disruptions from the Trump administration
Blog
Apr 1, 2025, 18:29
How EveryGrant is Helping Grantmakers Make a Global Impact - Conquer Cancer, the ASCO Foundation
Blog
Apr 1, 2025, 18:28
How tobacco smoking contributes to development of cancers of the head and neck - IARC/WHO
Blog
Apr 1, 2025, 18:26
Benjamin Perrotta: St. Baldricks was a success
Blog
Apr 1, 2025, 18:22
Last days to submit your abstract and topic proposal for SIOP 2025